Karavidas Maria Katsamanis, Lehrer Paul M, Vaschillo Evgeny, Vaschillo Bronya, Marin Humberto, Buyske Steven, Malinovsky Igor, Radvanski Diane, Hassett Afton
Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Appl Psychophysiol Biofeedback. 2007 Mar;32(1):19-30. doi: 10.1007/s10484-006-9029-z. Epub 2007 Mar 1.
Major depressive disorder (MDD) is a common mood disorder that can result in significant discomfort as well as interpersonal and functional disability. A growing body of research indicates that autonomic function is altered in depression, as evidenced by impaired baroreflex sensitivity, changes in heart rate, and reduced heart rate variability (HRV). Decreased vagal activity and increased sympathetic arousal have been proposed as major contributors to the increased risk of cardiovascular mortality in participants with MDD, and baroreflex gain is decreased.
To assess the feasibility of using HRV biofeedback to treat major depression.
This was an open-label study in which all eleven participants received the treatment condition. Participants attended 10 weekly sessions. Questionnaires and physiological data were collected in an orientation (baseline) session and Treatment Sessions 1, 4, 7 and 10.
Significant improvements were noted in the Hamilton Depression Scale (HAM-D) and the Beck Depression Inventory (BDI-II) by Session 4, with concurrent increases in SDNN, standard deviation of normal cardiac interbeat intervals) an electrocardiographic estimate of overall measure of adaptability. SDNN decreased to baseline levels at the end of treatment and at follow-up, but clinically and statistically significant improvement in depression persisted. Main effects for task and session occurred for low frequency range (LF) and SDNN. Increases in these variables also occurred during breathing at one's resonant frequency, which targets baroreflex function and vagus nerve activity, showing that subjects performed the task correctly.
HRV biofeedback appears to be a useful adjunctive treatment for the treatment of MDD, associated with large acute increases in HRV and some chronic increases, suggesting increased cardiovagal activity. It is possible that regular exercise of homeostatic reflexes helps depression even when changes in baseline HRV are smaller. A randomized controlled trial is warranted.
重度抑郁症(MDD)是一种常见的情绪障碍,可导致严重不适以及人际和功能障碍。越来越多的研究表明,抑郁症患者的自主神经功能会发生改变,压力反射敏感性受损、心率变化和心率变异性(HRV)降低就是证据。迷走神经活动减少和交感神经兴奋增加被认为是导致MDD患者心血管死亡风险增加的主要因素,压力反射增益降低。
评估使用HRV生物反馈治疗重度抑郁症的可行性。
这是一项开放标签研究,所有11名参与者都接受了治疗。参与者每周参加10次治疗。在基线期、治疗第1、4、7和10次时收集问卷和生理数据。
到第4次治疗时,汉密尔顿抑郁量表(HAM-D)和贝克抑郁量表(BDI-II)有显著改善,同时正常心搏间期标准差(SDNN,心电图对整体适应性测量的估计值)增加。治疗结束时和随访时SDNN降至基线水平,但抑郁症在临床和统计学上仍有显著改善。低频范围(LF)和SDNN在任务和治疗阶段有主要影响。在以共振频率呼吸时,这些变量也会增加,该频率针对压力反射功能和迷走神经活动,表明受试者正确完成了任务。
HRV生物反馈似乎是治疗MDD的一种有用辅助治疗方法,与HRV的大幅急性增加和一些慢性增加相关,表明心迷走神经活动增加。即使基线HRV变化较小,定期进行稳态反射训练也可能有助于治疗抑郁症。有必要进行一项随机对照试验。